Hypereosinophilic syndrome (Q101690): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed an Item |
||||||||||||||
| (6 intermediate revisions by the same user not shown) | |||||||||||||||
| description / pt-br | description / pt-br | ||||||||||||||
Síndrome hipereosinofílica (SHE) constitui um grupo raro e heterogêneo de transtornos, definido como eosinofilia sanguínea persistente e acentuada (maior que 1,5 x 10 [9a potência]/L por mais de seis meses consecutivos, associada a evidências de danos a órgãos induzidos por eosinófilos, quando outras causas de hipereosinofilia, como transtornos alérgicos, parasitários e malignos, foram excluídos._x000D_ _x000D_ Informações adicionais: As apresentações clínicas variam, desde envolvimento cutâneo benigno até manifestações graves, como endomiocardiofibrose e tromboembolismo. Os subtipos incluem a associação com a síndrome de Churg-Strauss (granulomatose eosinofílica com poliangiite), neoplasias mieloides, variante linfocítica de células T e endocardite de Loeffler, assim como a idiopática. | |||||||||||||||
| description / en | description / en | ||||||||||||||
Hypereosinophilic syndrome (HES) constitute a rare and heterogeneous group of disorders, defined as persistent and marked blood eosinophilia (greater than 1.5 x 10[9th power]/L for more than six consecutive months, associated with evidence of eosinophil-induced organ damage, where other causes of hypereosinophilia such as allergic, parasitic, and malignant disorders have been excluded. Additional information: Clinical presentations vary, from benign cutaneous involvement to severe manifestations such as endomyocardial fibrosis and thromboembolism. Subtypes include the association with Churg-Strauss syndrome (eosinophilic granulomatosis with polyangiitis), myeloid neoplasms, T cell lymphocytic variant and Loeffler's endocarditis, as well as idiopathic. | |||||||||||||||
| Property / Canonical URI | |||||||||||||||
| Property / Canonical URI: https://id.who.int/icd/entity/110429919 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / CURIE | |||||||||||||||
CID11:ID_110429919 | |||||||||||||||
| Property / CURIE: CID11:ID_110429919 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Canary Token | |||||||||||||||
dki-india-ID_110429919 | |||||||||||||||
| Property / Canary Token: dki-india-ID_110429919 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Verification Status | |||||||||||||||
Concluído | |||||||||||||||
| Property / Verification Status: Concluído / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Knowledge Architect | |||||||||||||||
| Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Collection date | |||||||||||||||
15 August 2026
| |||||||||||||||
| Property / Collection date: 15 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 18:32, 16 August 2026
Hypereosinophilic syndrome (HES) constitute a rare and heterogeneous group of disorders, defined as persistent and marked blood eosinophilia (greater than 1.5 x 10[9th power]/L for more than six consecutive months, associated with evidence of eosinophil-induced organ damage, where other causes of hypereosinophilia such as allergic, parasitic, and malignant disorders have been excluded. Additional information: Clinical presentations vary, from benign cutaneous involvement to severe manifestations such as endomyocardial fibrosis and thromboembolism. Subtypes include the association with Churg-Strauss syndrome (eosinophilic granulomatosis with polyangiitis), myeloid neoplasms, T cell lymphocytic variant and Loeffler's endocarditis, as well as idiopathic.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_110429919 |
||
| English | Hypereosinophilic syndrome |
Hypereosinophilic syndrome (HES) constitute a rare and heterogeneous group of disorders, defined as persistent and marked blood eosinophilia (greater than 1.5 x 10[9th power]/L for more than six consecutive months, associated with evidence of eosinophil-induced organ damage, where other causes of hypereosinophilia such as allergic, parasitic, and malignant disorders have been excluded. Additional information: Clinical presentations vary, from benign cutaneous involvement to severe manifestations such as endomyocardial fibrosis and thromboembolism. Subtypes include the association with Churg-Strauss syndrome (eosinophilic granulomatosis with polyangiitis), myeloid neoplasms, T cell lymphocytic variant and Loeffler's endocarditis, as well as idiopathic. |
Statements
CID11:ID_110429919
0 references
dki-india-ID_110429919
0 references
Concluído
0 references
15 August 2026
0 references
